Akero Therapeutics GAAP EPS of -$0.86 beats by $0.11 (NASDAQ:AKRO)
Akero Therapeutics press release (NASDAQ:AKRO): Q2 GAAP EPS of -$0.86 beats by $0.11. Akero's cash, cash equivalents and short and ...
Monday, January 26, 2026
Tag: NASDAQAKRO
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.